Literature DB >> 3167506

Lipids and platelet function in runners.

J R Haigh1, C A Fruin, R Pinn, E J Lea.   

Abstract

The effect of distance running on the fatty acid composition of platelet and erythrocyte membranes has been investigated, together with platelet aggregation and levels of high density lipoprotein-cholesterol (HDLc), low density lipoprotein cholesterol (LDLc), total cholesterol and triglycerides in runners (n = 11) and healthy age-matched non-running controls (n = 12). Platelet aggregation and fatty acid composition of membrane lipids in both platelets and erythrocytes are similar in both groups with the following exceptions: in platelets docosahexaenoic acid (C22:6 omega 3) is significantly higher in runners; in erythrocytes the fatty acids C20:3 omega 6/C22:1 omega 9 and C22:5 omega 3 are significantly higher in runners. There were no significant differences between the levels of HDLc, LDLc and total cholesterol in runners and controls although triglycerides were significantly lower in runners. Possible beneficial effects of running are probably mediated through effects on serum lipid and lipoprotein concentrations, and probably not due to any antithrombotic effect of platelets.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3167506      PMCID: PMC1478557          DOI: 10.1136/bjsm.22.2.66

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  29 in total

1.  Platelet function and serum high density lipoproteins.

Authors:  A Nordøy; N Refsum; D Thelle; S Jaeger
Journal:  Thromb Haemost       Date:  1979-12-21       Impact factor: 5.249

2.  Plasma lipoprotein distributions in male and female runners.

Authors:  P D Wood; W L Haskell; M P Stern; S Lewis; C Perry
Journal:  Ann N Y Acad Sci       Date:  1977       Impact factor: 5.691

Review 3.  Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.

Authors:  S Moncada; J R Vane
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

Review 6.  Dietary prevention of ischaemic heart disease--a policy for the '80s.

Authors:  B Lewis
Journal:  Br Med J       Date:  1980-07-19

7.  Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men.

Authors:  G H Hartung; J P Foreyt; R E Mitchell; I Vlasek; A M Gotto
Journal:  N Engl J Med       Date:  1980-02-14       Impact factor: 91.245

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  HDL-cholesterol and other plasma lipid and lipoprotein concentrations in middle-aged male and female tennis players.

Authors:  P A Vodak; P D Wood; W L Haskell; P T Williams
Journal:  Metabolism       Date:  1980-08       Impact factor: 8.694

10.  A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein.

Authors:  P N Demacker; A G Hijmans; H E Vos-Janssen; A van't Laar; A P Jansen
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.